Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kollins John A Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Kollins John A (President and CEO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Unknown transaction of 305,911 shares @ $0.91, valued at $278.4k
Disposed/sold 175,000 options to buy @ $29, valued at $5.1M
Disposed/sold 240,000 options to buy @ $4.6, valued at $1.1M
Disposed/sold 505,000 options to buy @ $3.46, valued at $1.7M
Disposed/sold 276,595 options to buy @ $4.56, valued at $1.3M
Disposed/sold 127,659 options to buy @ $1.04, valued at $132.8k
Disposed/sold 127,659 options to buy @ $0.9, valued at $114.9k
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Kollins John A (President and CEO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Granted 240,000 options to buy @ $4.6, valued at $1.1M
03/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/30/2014 4 Kollins John A (SVP, Chief Business Officer) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 4,161 shares @ $21.588, valued at $89.8k
Disposed/sold 4,166 options to buy @ $0
Disposed/sold 7,083 options to buy @ $0
Disposed/sold 7,500 options to buy @ $0
Disposed/sold 9,583 options to buy @ $0
06/05/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
07/18/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
01/08/2013 4 Kollins John A (SVP, Chief Business Officer) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 90,000 options to buy @ $5.4, valued at $486k
06/21/2012 4 Kollins John A (SVP, Chief Business Officer) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 85,000 options to buy @ $6.11, valued at $519.4k
01/22/2009 4 Kollins John A (CEO) has filed a Form 4 on OXIGENE INC
12/18/2008 4 Kollins John A (CEO) has filed a Form 4 on OXIGENE INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy